Im­munother­a­py biotech rais­es $37M from back­ers like Pfiz­er, Take­da, BMS

Im­munother­a­py biotech EvolveIm­mune Ther­a­peu­tics raised $37 mil­lion in a fi­nanc­ing round, backed by big names like Pfiz­er and its newest in­vestor, Bris­tol My­ers Squibb. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER